DOCK2 and colorectal carcinoma: Oncogenomic analysis showed that a notable proportion of their downregulation is probably attributable to truncating mutations (Fig. 7B), although it seems that transcriptional and post-translational regulatory mechanisms are involved in the down-regulation of DOCK2 and PTPRC2 in CRC.